Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
TGen scientists identify potent inhibitory compound for treatment against glioblastoma

TGen scientists identify potent inhibitory compound for treatment against glioblastoma

Researchers identify brain cell types from cell culture of adult human neurons

Researchers identify brain cell types from cell culture of adult human neurons

Duke researchers use cancer-seeking salmonella to treat glioblastoma

Duke researchers use cancer-seeking salmonella to treat glioblastoma

New research suggests novel combination approach to fight against gliomas

New research suggests novel combination approach to fight against gliomas

NFCR scientists develop new treatment for brain cancer

NFCR scientists develop new treatment for brain cancer

Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

Novel genomics model allows personalized approach to radiation therapy

Novel genomics model allows personalized approach to radiation therapy

New graphene system can detect activity levels of interfaced normal and cancer cells

New graphene system can detect activity levels of interfaced normal and cancer cells

Researchers identify attractive drug candidate to target glioma tumors

Researchers identify attractive drug candidate to target glioma tumors

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Metabolic pathway that shows potential to slow aging may drive brain cancer

Metabolic pathway that shows potential to slow aging may drive brain cancer

Ancient Japanese art inspires groundbreaking technique to create ‘artificial brains’

Ancient Japanese art inspires groundbreaking technique to create ‘artificial brains’

Researchers design smart drug to treat patients with most aggressive brain cancers

Researchers design smart drug to treat patients with most aggressive brain cancers

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Cancer researchers identify important driver of tumor cell invasion in glioblastoma

Cancer researchers identify important driver of tumor cell invasion in glioblastoma

Deficiency of tumor suppressor gene may allow brain cancer cells to survive outside niches

Deficiency of tumor suppressor gene may allow brain cancer cells to survive outside niches

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

Characteristics of brain tumour provide insight into survival, treatment options for patients over 70

Characteristics of brain tumour provide insight into survival, treatment options for patients over 70

Research shows potential way to counteract glioblastoma growth by blocking PPARα receptor

Research shows potential way to counteract glioblastoma growth by blocking PPARα receptor

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.